Skip to content
Catalyst

PapersPMID:35728870

L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression.

Journal for immunotherapy of cancer2022The record ↗

  1. Finding, insufficient evidencelowersCD274

What moved

1 findingHow to read these marks →
  • Inhibits CD274

    insufficient

    “In syngeneic mouse tumor models, treatment with 100 mg/kg L-5-HTP (intraperitoneal) inhibited PD-L1 expression and exhibited antitumor effect.”
    Study
    animal · not in humans
    Dose studied
    100 mg/kg intraperitoneal
    Population
    syngeneic mouse tumor models

Study record

Design
animal study, in vivo / mechanistic study
Species
mixed
Population
cell-based flow-cytometry screen of 200 metabolic molecules and syngeneic mouse tumor models
Participants
not reported
Comparator
an active treatment
Duration
not reported
Endpoints measured
3